ScholarIQanswers from OpenAlex
Bristol-Myers Squibb (Sweden)
InstitutionResearch output, impact & collaborations
Bristol-Myers Squibb (Sweden) is a institution indexed in ScholarIQ from OpenAlex.
What is known about Bristol-Myers Squibb (Sweden)?
ScholarIQrecord summary
Bristol-Myers Squibb (Sweden) is a research organisation in Solna, SE. OpenAlex records 2,493 works and 278,596 citations for it. 906 researchers list it as their most recent affiliation.
How many works does Bristol-Myers Squibb (Sweden) have?
ScholarIQindexed works
Bristol-Myers Squibb (Sweden) has 2,493 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Bristol-Myers Squibb (Sweden) have?
ScholarIQcitation count
Bristol-Myers Squibb (Sweden) has 278,596 citations in the OpenAlex counts ScholarIQ stores.
How many researchers are at Bristol-Myers Squibb (Sweden)?
ScholarIQresearcher count
Bristol-Myers Squibb (Sweden) has 906 researchers in the ScholarIQ index.
What is the average h-index at Bristol-Myers Squibb (Sweden)?
ScholarIQavg h-index
Bristol-Myers Squibb (Sweden) has an average h-index of 38.7 in OpenAlex.
What is the ROR of Bristol-Myers Squibb (Sweden)?
ScholarIQror
The ROR for Bristol-Myers Squibb (Sweden) is on the source record.
What is the OpenAlex record for Bristol-Myers Squibb (Sweden)?
ScholarIQopenalex
The OpenAlex for Bristol-Myers Squibb (Sweden) is on the source record.
Who are the most-cited researchers behind Bristol-Myers Squibb (Sweden)?
ScholarIQtop researchers by citations
What are the most-cited papers on Bristol-Myers Squibb (Sweden)?
ScholarIQmost cited works
Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
Robert L. Ferris, George R. Blumenschein, Jérôme Fayette, J. Guigay, A. Dimitrios Colevas, Lisa Licitra, Kevin J. Harrington, Stefan Kasper, Everett E. Vokes, Caroline Even, Francis P. Worden, Nabil F. Saba, Lara Carmen Iglesias Docampo, Robert I. Haddad, Tamara Rordorf, Naomi Kiyota, Makoto Tahara, Manish Monga, Mark Lynch, William J. Geese, Justin Kopit, James W. Shaw, Maura L. Gillison
Nivolumab plus Ipilimumab in Lung Cancer with a High Tumor Mutational Burden
Matthew D. Hellmann, Tudor–Eliade Ciuleanu, Adam Płużański, Jong Seok Lee, Gregory A. Otterson, Clarisse Audigier-Valette, Elisa Minenza, Helena Linardou, Sjaak A. Burgers, Pamela Salman, Hossein Borghaei, Suresh S. Ramalingam, Julie R. Brahmer, Martin Reck, Kenneth J. O’Byrne, William J. Geese, George Green, Chang Han, Joseph D. Szustakowski, Prabhu Bhagavatheeswaran, Diane Healey, Yali Fu, Faith E. Nathan, Luis Paz‐Ares
Nivolumab plus Ipilimumab in Advanced Non–Small-Cell Lung Cancer
Matthew D. Hellmann, Luis Paz‐Ares, Reyes Bernabe Caro, Bogdan Żurawski, Sang‐We Kim, Enric Carcereny, Keunchil Park, Aurelia Alexandru, Lorena Lupinacci, Emmanuel de la Mora Jimenez, Hiroshi Sakai, István Albert, A. Vergnenègre, Solange Peters, Konstantinos Syrigos, Fabrice Barlési, Martin Reck, Hossein Borghaei, Julie R. Brahmer, Kenneth J. O’Byrne, William J. Geese, Prabhu Bhagavatheeswaran, Sridhar K. Rabindran, Ravi S. Kasinathan, Faith E. Nathan, Suresh S. Ramalingam
First-Line Nivolumab in Stage IV or Recurrent Non–Small-Cell Lung Cancer
David P. Carbone, Martin Reck, Luis Paz‐Ares, Ben Creelan, Leora Horn, Martin Steins, Enriqueta Felip, Michel M. van den Heuvel, Tudor–Eliade Ciuleanu, Firas Badin, Neal Ready, T. Jeroen N. Hiltermann, Suresh Nair, Rosalyn A. Juergens, Solange Peters, Elisa Minenza, John Wrangle, Delvys Rodríguez‐Abreu, Hossein Borghaei, George R. Blumenschein, Liza C. Villaruz, Libor Havel, Jana Krejčí, Jesus Corral Jaime, Han Chang, William J. Geese, Prabhu Bhagavatheeswaran, Allen C. Chen, Mark A. Socinski
Idecabtagene Vicleucel in Relapsed and Refractory Multiple Myeloma
Nikhil C. Munshi, Larry D. Anderson, Nina Shah, Deepu Madduri, Jesús G. Berdeja, Sagar Lonial, Noopur Raje, Yi Lin, David S. Siegel, Albert Oriol, Philippe Moreau, Ibrahim Yakoub‐Agha, Michel Delforge, Michèle Cavo, Hermann Einsele, Hartmut Goldschmidt, Katja Weisel, Alessandro Rambaldi, Donna Reece, Fabio Petrocca, Monica Massaro, Jamie N. Connarn, Shari M. Kaiser, Payal Patel, Liping Huang, Timothy Campbell, Kristen Hege, Jesús F. San Miguel
How much of the research on Bristol-Myers Squibb (Sweden) is open access?
ScholarIQopen access share
83%OPEN ACCESS